|
|
|
|
|
The
Next Big Destination
Come next month and the much-awaited International Biotech
Park (IBP) in Pune-the Silicon Valley of western India-will
be ready for operations. Prasanta Biswal, Chief Executive
Officer, IBP reveals in an exclusive to Divya Nair, what makes
this business park unique.
|
|
|
|
| |
|
|
|
|
|
|
|
|
IN
THE NEWS
|
IN-DEPTH
|
|
American
weight loss product launched in Bangalore
The New Delhi based Ochoa Laboratories has introduced
‘Amylofix’ an American brand of weight loss
product extracted from bikidney beans (Phaseolus vulgaris)
in the Indian market. The formal launch was held in
the city recently.
|
Stem cells:
Beyond embryonic stage
The uncertain regulatory environment in the US might
have raised ethical and religious issues relating to
stem cell research some forms of research involve using
human embryos. However, stem cell technology is the
next big wave and a buzzword in the scientific community
in India. There has been increasing activity in stem
cell research in recent times in both public and private
sectors and there are no political or faith-based objections.
|
|
TECHNOLOGY
TRENDZ
|
HEALTH
NEWS
|
|
Chemical
Drug Delivery Systems: Strategies And Applications
Despite the considerable progress of the last century,
rational drug design that allows the development of
effective pharmaceutical agents with minimal side effects
remains an elusive goal. Many therapeutic drugs have
undesirable properties that may become pharmacological,
pharmaceutical or pharmacokinetic barriers in clinical
drug applications.
|
Indian
Nursing Council plans a slew of initiatives
In a bid to boost the nursing sector, the Indian Nursing
Council (INC), the parent body of the nursing councils
in the country, has rolled out a series of initiatives,
many of which are in the early implementation stage,
while the rest have been forwarded by INC for approval
to the Union Health ministry.
|
|
CORPORATE
|
MARKETPLACE
|
|
Humalog
Mixture is the latest innovation in diabetes care
Eli Lilly brings a first of its kind insulin mixture
that caters specifically to the Indian patient.
|
Sun
Pharma gets stake in Valeant
Sun Pharmaceutical Industries has said that it had acquired
a stake in ICN Company Hungary from Valeant Pharma-ceuticals
International. The purchase of the raw materials and
dosage form manufacturing operations in Hungary gave
Sun an early opportunity to enter the European generic
market, its Chairman Dilip Shanghvi said in a statement.
|
|
CONVERSATION
|
|
‘Ensuring
data protection is crucial for clinical activity’
Incorporated in India in 1994, Roche Scientific Company
(India), is a wholly owned subsidiary of the Basel (Switzerland)-based
F Hoffmann LA Roche (FHLR). In 1993, FHLR entered into
an agreement with Nicholas Piramal India to market and
manufacture some of its products, but this was terminated
in 2003. Roche is now going on its own, and launching
Avastin, its cancer drug, here, just a few months after
its global launch. Dr G Telang, the company’s Managing
Director, spoke to MG Arun on the new patent scenario
and Roche’s future plans in India.
|
|
|
|
|
|
